CAS No.106560-14-9,Faropenem sodium hemipentahydrate Suppliers

Products Categories

Pharmaceutical (82)
Organic Chemicals (17)
Others (16)
Reagent (2)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	106560-14-9
Name:	Faropenem sodium hemipentahydrate
Article Data:	3

Formula:	C₁₂H₁₅NO₅S
Molecular Weight:	285.321
Synonyms:	4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, [5R-[3(R),5a,6a(R)]]-;(+)-(5R,6S)-6-[(1R)-1-Hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid;(5R,6S,8R,2'R)-2-(2'-tetrahydrofuryl)-6-(1-hydroxyethyl)-2-penem-3-carboxylicacid;
EINECS:	1312995-182-4
Density:	1.569 g/cm³
Boiling Point:	570.249 °C at 760 mmHg
Flash Point:	298.676 °C
Appearance:	Light yellow powder
Risk Codes:	R20/21/22
PSA:	112.37000
LogP:	0.31160

Synthetic route

: 1004548-62-2
(5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; sodium hydrogencarbonate; 5%-palladium/activated carbon In water; ethyl acetate at 20 - 30℃; under 4413.43 - 5149.01 Torr; Stage #2: With hydrogenchloride In water for 1h; pH=1.8 - 2.0; Product distribution / selectivity;
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran; water at 20 - 30℃; under 4413.43 - 5149.01 Torr; pH=7; Aqueous phosphate buffer; Stage #2: With disodium hydrogenphosphate In tetrahydrofuran; water pH=6.8 - 7.0; Aqueous phosphate buffer; Stage #3: With hydrogenchloride In water for 1h; pH=1.8 - 2.0; Product distribution / selectivity;
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran at 20 - 25℃; under 4413.43 - 5149.01 Torr; pH=7; Autoclave; Phosphate buffer; Inert atmosphere; Stage #2: With hydrogenchloride; water pH=1.8 - 2.0; Product distribution / selectivity; Inert atmosphere;

: R-(+)-thio tetrahydrofuran-2-carboxylic acid

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: sodium hydroxide / acetone / 2 h / 0 - 20 °C / pH 8 - 10 2: triethylamine / dichloromethane / 2 h / 0 - 5 °C 3: triethyl phosphite / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / Reflux 4: hydrogenchloride; palladium on activated charcoal; hydrogen / methanol / 16 h / 40 °C / 3040.2 Torr View Scheme

: 76899-07-5, 78963-47-0, 78963-48-1, 78963-60-7, 80951-41-3, 81275-02-7, 85647-75-2, 85954-95-6, 92217-74-8, 104527-11-9, 76855-69-1
(3R,4R)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-acetoxyazetidin-2-one

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: sodium hydroxide / acetone / 2 h / 0 - 20 °C / pH 8 - 10 2: triethylamine / dichloromethane / 2 h / 0 - 5 °C 3: triethyl phosphite / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / Reflux 4: hydrogenchloride; palladium on activated charcoal; hydrogen / methanol / 16 h / 40 °C / 3040.2 Torr View Scheme

: 106560-32-1
(R)-Tetrahydro-furan-2-carbothioic acid S-{(2R,3S)-3-[(R)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidin-2-yl} ester

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 1: triethylamine / dichloromethane / 2 h / 0 - 5 °C 2: triethyl phosphite / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / Reflux 3: hydrogenchloride; palladium on activated charcoal; hydrogen / methanol / 16 h / 40 °C / 3040.2 Torr View Scheme

: C25H34N2O9SSi

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: triethyl phosphite / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / Reflux 2: hydrogenchloride; palladium on activated charcoal; hydrogen / methanol / 16 h / 40 °C / 3040.2 Torr View Scheme

: C25H34N2O7SSi

: 106560-14-9
faropenem

Conditions

Conditions	Yield
With hydrogenchloride; palladium on activated charcoal; hydrogen In methanol at 40℃; under 3040.2 Torr; for 16h;

C25H34N2O7SSi: C25H34N2O7SSi

Conditions

Conditions	Yield
With hydrogenchloride; palladium on activated charcoal; hydrogen In methanol at 40℃; under 3040.2 Torr; for 16h;

Conditions

Conditions	Yield
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; sodium hydrogencarbonate; 5%-palladium/activated carbon In water; ethyl acetate at 20 - 30℃; under 4413.43 - 5149.01 Torr; Stage #2: With hydrogenchloride In water for 1h; pH=1.8 - 2.0; Product distribution / selectivity;
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran; water at 20 - 30℃; under 4413.43 - 5149.01 Torr; pH=7; Aqueous phosphate buffer; Stage #2: With disodium hydrogenphosphate In tetrahydrofuran; water pH=6.8 - 7.0; Aqueous phosphate buffer; Stage #3: With hydrogenchloride In water for 1h; pH=1.8 - 2.0; Product distribution / selectivity;
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran at 20 - 25℃; under 4413.43 - 5149.01 Torr; pH=7; Autoclave; Phosphate buffer; Inert atmosphere; Stage #2: With hydrogenchloride; water pH=1.8 - 2.0; Product distribution / selectivity; Inert atmosphere;

: 1004548-62-2
(5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; sodium hydrogencarbonate; 5%-palladium/activated carbon In water; ethyl acetate at 20 - 30℃; under 4413.43 - 5149.01 Torr; Stage #2: With hydrogenchloride In water for 1h; pH=1.8 - 2.0; Product distribution / selectivity;
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran; water at 20 - 30℃; under 4413.43 - 5149.01 Torr; pH=7; Aqueous phosphate buffer; Stage #2: With disodium hydrogenphosphate In tetrahydrofuran; water pH=6.8 - 7.0; Aqueous phosphate buffer; Stage #3: With hydrogenchloride In water for 1h; pH=1.8 - 2.0; Product distribution / selectivity;
Stage #1: (5R,6S)-6-[1(R)-hydroxyethyl]-2-[2(R)-tetrahydrofuryl]penem-3-carboxylic acid 4-nitrobenzyl ester With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran at 20 - 25℃; under 4413.43 - 5149.01 Torr; pH=7; Autoclave; Phosphate buffer; Inert atmosphere; Stage #2: With hydrogenchloride; water pH=1.8 - 2.0; Product distribution / selectivity; Inert atmosphere;

: R-(+)-thio tetrahydrofuran-2-carboxylic acid

: 106560-14-9
faropenem

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: sodium hydroxide / acetone / 2 h / 0 - 20 °C / pH 8 - 10 2: triethylamine / dichloromethane / 2 h / 0 - 5 °C 3: triethyl phosphite / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / Reflux 4: hydrogenchloride; palladium on activated charcoal; hydrogen / methanol / 16 h / 40 °C / 3040.2 Torr View Scheme

Total:97 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 106560-14-9

History

FDA rejects Replidyne’s faropenem Louisville firm drug rejected; considered “nonapprovable’ 10/24/06 The US Food and Drug Administration (FDA) refused to approve faropenem, an antibiotic manufactured by Louisville-based Replidyne. The FDA said the drug was “nonapprovable,” but did not refer to specific safety concerns about the product.The company will have to conduct new studies and clinical trials, lasting an estimated two more years, to prove the drug treats community-acquired pneumonia, bacterial sinusitis, chronic bronchitis and skin infections.

Specification

The Faropenemsodiumhemipentahydrate, with the CAS registry number 106560-14-9, is also known as (+)-(5R,6S)-6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid. It belongs to the product category of API. This chemical's molecular formula is C₁₂H₁₅NO₅S and molecular weight is 285.32. What's more, its systematic name is (5R,6S)-6-[(1R)-1-Hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid. This chemical is an orally-active beta-lactam antibiotic belonging to the penem group. It is resistant to some forms of extended-spectrum beta-lactamase.

Physical properties of Faropenemsodiumhemipentahydrate are: (1)ACD/LogP: -1.087; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -2.57; (4)ACD/LogD (pH 7.4): -4.30; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 6; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 112.37 Å²; (13)Index of Refraction: 1.668; (14)Molar Refractivity: 67.785 cm³; (15)Molar Volume: 181.807 cm³; (16)Polarizability: 26.872×10^-24cm³; (17)Surface Tension: 76.44 dyne/cm; (18)Density: 1.569 g/cm³; (19)Flash Point: 298.676 °C; (20)Enthalpy of Vaporization: 98.247 kJ/mol; (21)Boiling Point: 570.249 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C2N1/C(=C(\S[C@@H]1[C@H]2[C@H](O)C)[C@@H]3OCCC3)C(=O)O
(2)Std. InChI: InChI=1S/C12H15NO5S/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6/h5-7,11,14H,2-4H2,1H3,(H,16,17)/t5-,6-,7+,11-/m1/s1
(3)Std. InChIKey: HGGAKXAHAYOLDJ-FHZUQPTBSA-N